This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hamel, F. G. Articles by Bennett, R. G. Search for Related Content PubMed PubMed Citation Articles by Hamel, F. G. Articles by Bennett, R. G.

In Vitro Inhibition of Insulin-Degrading Enzyme by Long-Chain Fatty Acids and Their Coenzyme A Thioesters

Research Service (F.G.H., J.L.U., R.G.B.), Department of Veterans Affairs Medical Center, Omaha, Nebraska 68105; and Departments of Internal Medicine (F.G.H., R.G.B.) and Pharmacology (F.G.H.), University of Nebraska Medical Center, Omaha, Nebraska 68198

Address all correspondence and requests for reprints to: Frederick G. Hamel, Ph.D., Department of Veterans Affairs Medical Center, 4101 Woolworth Avenue, Omaha, Nebraska 68105. E-mail: fghamel{at}unmc.edu.

Insulin-degrading enzyme is responsible for initiating insulin degradation in cells, but little is known about the factors controlling its activity. Because obesity and high levels of free fatty acids decrease insulin clearance, we examined the effect of some common free fatty acids and their acyl-coenzyme A thioesters on insulin-degrading enzyme partially purified from the livers of male Sprague Dawley rats. Octanoic acid (C8:0) had no effect on activity. Long-chain free fatty acids (C16–C20) inhibited between 50% and 90% of the insulin degradation with IC₅₀ values in the range of 10–50 µM. In general, the corresponding acyl-coenzyme A thioesters had lower IC₅₀ values and were slightly more efficacious. ¹²⁵I-insulin cross-linking studies showed free fatty acids did not inhibit hormone binding to insulin-degrading enzyme. Kinetic analysis showed a noncompetitive type of inhibition. Furthermore, fatty acids eliminated the ability of insulin to inhibit the proteasome. These results suggest that when intracellular long-chain fatty acid concentrations are elevated, they may act directly on insulin-degrading enzyme to decrease insulin metabolism and alter insulin action in intact cells. This mechanism may contribute to the hyperinsulinemia and insulin resistance seen with elevated fatty acids and obesity.

This article has been cited by other articles:

				H. Im, M. Manolopoulou, E. Malito, Y. Shen, J. Zhao, M. Neant-Fery, C.-Y. Sun, S. C. Meredith, S. S. Sisodia, M. A. Leissring, et al. Structure of Substrate-free Human Insulin-degrading Enzyme (IDE) and Biophysical Analysis of ATP-induced Conformational Switch of IDE J. Biol. Chem., August 31, 2007; 282(35): 25453 - 25463. [Abstract] [Full Text] [PDF]

				M. Kim, L. B. Hersh, M. A. Leissring, M. Ingelsson, T. Matsui, W. Farris, A. Lu, B. T. Hyman, D. J. Selkoe, L. Bertram, et al. Decreased Catalytic Activity of the Insulin-degrading Enzyme in Chromosome 10-Linked Alzheimer Disease Families J. Biol. Chem., March 16, 2007; 282(11): 7825 - 7832. [Abstract] [Full Text] [PDF]

				M. del Carmen Camberos and J. C. Cresto Insulin-Degrading Enzyme Hydrolyzes ATP Experimental Biology and Medicine, February 1, 2007; 232(2): 281 - 292. [Abstract] [Full Text] [PDF]

				H. Yoshii, T. K. T. Lam, N. Gupta, T. Goh, C. A. Haber, H. Uchino, T. T. Y. Kim, V. Z. Chong, K. Shah, I. G. Fantus, et al. Effects of portal free fatty acid elevation on insulin clearance and hepatic glucose flux Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1089 - E1097. [Abstract] [Full Text] [PDF]

				J. J. Kulstad, P. S. Green, D. G. Cook, G. S. Watson, M. A. Reger, L. D. Baker, S. R. Plymate, S. Asthana, K. Rhoads, P. D. Mehta, et al. Differential modulation of plasma {beta}-amyloid by insulin in patients with Alzheimer disease Neurology, May 23, 2006; 66(10): 1506 - 1510. [Abstract] [Full Text] [PDF]

				C. A. M. de Oliveira, E. Luciano, and M. A. R. de Mello The role of exercise on long-term effects of alloxan administered in neonatal rats Exp Physiol, January 1, 2005; 90(1): 79 - 86. [Abstract] [Full Text] [PDF]

				J. Gao, L. Ghibaudi, and J. J. Hwa Selective activation of central NPY Y1 vs. Y5 receptor elicits hyperinsulinemia via distinct mechanisms Am J Physiol Endocrinol Metab, October 1, 2004; 287(4): E706 - E711. [Abstract] [Full Text] [PDF]

				R. G. Bennett, F. G. Hamel, and W. C. Duckworth An Insulin-Degrading Enzyme Inhibitor Decreases Amylin Degradation, Increases Amylin-Induced Cytotoxicity, and Increases Amyloid Formation in Insulinoma Cell Cultures Diabetes, September 1, 2003; 52(9): 2315 - 2320. [Abstract] [Full Text] [PDF]